Amphastar Pharmaceuticals (AMPH) Interest Expenses (2013 - 2026)

Amphastar Pharmaceuticals' Interest Expenses history runs 14 years deep, the most recent figure standing at $6.6 million for Q1 2026.

• In Q1 2026, Interest Expenses rose 4.25% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $25.7 million (down 8.1% YoY), while the FY2025 annual figure was $25.5 million, down 16.02% from the prior year.
• Interest Expenses was $6.6 million for Q1 2026 at Amphastar Pharmaceuticals, down from $6.6 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $13.7 million in Q3 2023 to a low of $355000.0 in Q1 2022.
• Historically, Interest Expenses has averaged $5.4 million across 5 years, with a median of $6.3 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Interest Expenses jumped 2320.85% in 2023, then slumped 51.12% in 2024.
• A 5-year view of Interest Expenses shows it stood at $528000.0 in 2022, then soared by 1690.91% to $9.5 million in 2023, then tumbled by 32.05% to $6.4 million in 2024, then grew by 3.19% to $6.6 million in 2025, then decreased by 1.16% to $6.6 million in 2026.
• The last three Interest Expenses figures came in at $6.6 million (Q1 2026), $6.6 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.